These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21315153)
1. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis. Leask A Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153 [TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. Shiwen X; Leask A; Abraham DJ; Fonseca C Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743 [TBL] [Abstract][Full Text] [Related]
3. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Leask A Cell Signal; 2008 Aug; 20(8):1409-14. PubMed ID: 18296024 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379 [TBL] [Abstract][Full Text] [Related]
5. Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis. Elisa T; Antonio P; Giuseppe P; Alessandro B; Giuseppe A; Federico C; Marzia D; Ruggero B; Giacomo M; Andrea O; Daniela R; Mariaelisa R; Claudio L J Immunol Res; 2015; 2015():147616. PubMed ID: 26090478 [TBL] [Abstract][Full Text] [Related]
6. Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Leask A Front Biosci (Elite Ed); 2009 Jun; 1(1):115-22. PubMed ID: 19482630 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. Liu X; Zhu S; Wang T; Hummers L; Wigley FM; Goldschmidt-Clermont PJ; Dong C PLoS Med; 2005 Dec; 2(12):e354. PubMed ID: 16250671 [TBL] [Abstract][Full Text] [Related]
10. Scar wars: is TGFbeta the phantom menace in scleroderma? Leask A Arthritis Res Ther; 2006; 8(4):213. PubMed ID: 16774692 [TBL] [Abstract][Full Text] [Related]
11. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556 [TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor antagonism--new perspectives in the treatment of systemic sclerosis. Kowal-Bielecka O; Sierakowski S Rocz Akad Med Bialymst; 2005; 50 Suppl 1():291-3. PubMed ID: 16119689 [TBL] [Abstract][Full Text] [Related]
13. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964 [TBL] [Abstract][Full Text] [Related]
14. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Shi-Wen X; Rodríguez-Pascual F; Lamas S; Holmes A; Howat S; Pearson JD; Dashwood MR; du Bois RM; Denton CP; Black CM; Abraham DJ; Leask A Mol Cell Biol; 2006 Jul; 26(14):5518-27. PubMed ID: 16809784 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast abnormalities in the pathogenesis of systemic sclerosis. Usategui A; del Rey MJ; Pablos JL Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292 [TBL] [Abstract][Full Text] [Related]
16. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
17. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis. Dees C; Tomcik M; Palumbo-Zerr K; Distler A; Beyer C; Lang V; Horn A; Zerr P; Zwerina J; Gelse K; Distler O; Schett G; Distler JH Arthritis Rheum; 2012 Sep; 64(9):3006-15. PubMed ID: 22549363 [TBL] [Abstract][Full Text] [Related]
19. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Shi-wen X; Kennedy L; Renzoni EA; Bou-Gharios G; du Bois RM; Black CM; Denton CP; Abraham DJ; Leask A Arthritis Rheum; 2007 Dec; 56(12):4189-94. PubMed ID: 18050250 [TBL] [Abstract][Full Text] [Related]
20. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2). Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]